Literature DB >> 3061830

Effect of a prostacyclin analog OP-2507 on acute ischemic cerebral edema in cats.

T Terawaki1, T Takakuwa, S Iguchi, K Wakitani, H Kira, T Okegawa, A Kawasaki, Y Masuda.   

Abstract

We evaluated the inhibitory activity of a novel prostacyclin analog, OP-2507 (15-cis-(4-n-propylcyclohexyl)-16,17,18,19,20-pentanor-9-deo xy-6,9 alpha- nitriloprostaglandin F1 methyl ester) on the brain edema induced by occlusion of the middle cerebral artery in cats. Middle cerebral artery occlusion for 4h caused a decrease of regional cerebral blood flow. The specific gravity of the cerebral cortex measured 4h after the middle cerebral artery occlusion as an index of cerebral edema showed a significant reduction. Intravenous infusion of OP-2507 at infusion rates of 10 and 50 ng/kg per min was started 30 min before the middle cerebral artery occlusion and was continued for 4.5 h. While OP-2507 did not affect the blood pressure, heart rate and regional cerebral blood flow before and after the middle cerebral artery occlusion, the reduction of the specific gravity of cerebral cortex was significantly prevented by OP-2507 treatment at both doses. Prostacyclin prevented the reduction of the specific gravity only at the higher dose of 50 ng/kg per min. The present results indicate the potential usefulness of OP-2507 in acute ischemic cerebral disorders.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3061830     DOI: 10.1016/0014-2999(88)90836-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Protective effect of beraprost sodium, a new chemically stable prostacyclin analogue, against the deterioration of baroreceptor reflex following transient global cerebral ischaemia in dogs.

Authors:  J Kurihara; T Sahara; H Kato
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

2.  Attenuation of ischemia reperfusion-induced lung edema by prostaglandin I2 analogue OP-2507 in the isolated perfused rat lung.

Authors:  Masahiro Okuda; Kazuhisa Furuhashi; Yasushi Nakai; Homare Amano; Mannosuke Muneyuki
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

3.  Prostacyclin prevents pericyte loss and demyelination induced by lysophosphatidylcholine in the central nervous system.

Authors:  Rieko Muramatsu; Mariko Kuroda; Ken Matoba; Hsiaoyun Lin; Chisato Takahashi; Yoshihisa Koyama; Toshihide Yamashita
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

4.  Effects of prostacyclin analogue, OP-2507, on function and metabolism in the ischemic working rat heart.

Authors:  T Oguchi; S Kashimoto; T Nakamura; T Kumazawa
Journal:  J Anesth       Date:  1992-10       Impact factor: 2.078

5.  Protective effects of prostaglandin I2 analogues on CPK release in rat's heart-lung preparation.

Authors:  S Kashimoto; T Nakamura; T Oguchi; M Kume; T Kumazawa
Journal:  J Anesth       Date:  1991-10       Impact factor: 2.078

6.  Signalling architectures can prevent cancer evolution.

Authors:  Leonardo Oña; Michael Lachmann
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.